The Cure Starts Now follows an extensive grant approval process to ensure your dollars make the biggest impact to homerun cancer research. Take comfort in knowing that The Cure Starts Now only funds: research that follows our mission, research that is non-duplicative, and research that is financially sound.


The Cure Starts Now has funded $24,388,300 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 156 grants at over 100 hospitals in 29 countries.




Cincinnati Children's Hospital Medical Center - $100,000

Amount
$100,000.00
Date
December 2015

An early Phase 2 Study of LEE011, a CDK4/6 Inhibitor, following radiation therapy in Children with Newly Diagnosed non-biopsied Diffuse Pontine Gliomas (DIPG) and Rb+ biopsied DIPG and High Grade Gliomas (HGG)

Baylor College of Medicine/Texas Children's Hospital - $200,000

Amount
$200,000.00
Date
December 2015

Targeting DIPGs through Super-activation of Steroid Receptor Co-activators: An in vivo Study in Patient-derived Intra-brain Stem Xenograft Mouse Models

Children's National Health System and Children's Research Institute - $125,000

Amount
$125,000.00
Date
December 2015

Comprehensive Molecular-Based Cross-Species Comparison of DIPG Biology

Boston Children's Hospital - $110,000

Amount
$110,000.00
Date
December 2015

Enabling epigenetic therapies by exploring DIPG chromatin sensitivities

UCL Institute of Child Health - $200,000

Amount
$200,000.00
Date
December 2015

T-cell based immunotherapy for DIPG.

Dana Farber Cancer Institute - $82,863

Amount
$82,863.00
Date
December 2015

Discovering novel epigenetic dependencies in Diffuse Intrinsic Pontine Glioma

VU University Medical Center - $92,950

Amount
$92,950.00
Date
November 2015

Liquid Biopsies for the Monitoring of Diffuse Intrinsic Pontine Glioma.

Children's Cancer Institute - $145,341

Amount
$145,341.00
Date
November 2015

Fenretinide, a novel agent targeting RTK/PI3K/AKT network for the treatment of Diffuse Intrinsic Pontine Glioma.

Cincinnati Children's Hospital Medical Center - $200,000

Amount
$200,000.00
Date
October 2015

Intra-tumoral heterogeneity in diffuse intrinsic pontine and midline high-grade gliomas

The Hospital for Sick Children - $190,905

Amount
$190,905.00
Date
October 2015

Mitochondrial DNA alterations and their potential as a novel therapeutic target in DIPG

Children's National Medical Center - $200,000

Amount
$200,000.00
Date
October 2015

Evaluating TORC1/2 kinase inhibition in murine and nonhuman primate (NHP) models

European DIPG Registry - $445,870.12

Amount
$445,870.00
Date
September 2015

European DIPG Registry.

Institute of Cancer Research - $99,470

Amount
$99,470.00
Date
September 2015

The Evolutionary Dynamics of Diffuse Intrinsic Pontine Glioma.

Stanford University Medical Center - $200,000

Amount
$200,000.00
Date
September 2015

Targeting neuronal activity-regulated DIPG infiltration

International DIPG Registry - $699,935

Amount
$699,935.00
Date
August 2015

Establishment of an International Diffuse Intrinsic Pontine Glioma (DIPG) Registry